Menu
LivaNova PLC is a global medical technology and innovation company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through innovative medical technologies, delivering life-changing improvements for both the Head and Heart. Headquartered in London, LivaNova employs approximately 4,000 employees and has a presence in more than 100 countries for the benefit of patients, healthcare professionals and healthcare systems worldwide.
20 Eastbourne Terrace, London W2 6LG
Phone: 442033250662
www.livanova.com
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that Marco Dolci intends to retire as President of the Cardiopulmonary (CP) Business Unit (BU) by December…
U.K.-based medical device maker LivaNova PLC (LIVN) has received the U.S. and EU regulatory clearances for its Essenz In-Line Blood Monitor. Read more here.
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance and CE Mark for its Essenz In-Line Bl…
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Bill Kozy, Interim Chief Executive Officer and Board Chair of LivaNova, will present in a fireside chat at…
Mirae Asset Global Investments Co. Ltd. grew its stake in shares of LivaNova PLC (NASDAQ:LIVN – Free Report) by 3.3% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 26,047 shares of the company’s stock after purchasing an additional 836 shares during the […]